Career Enhancement Program
Career Enhancement Program
批准号:
10478884
负责人:
Charles David James
金额:
$7.85万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-08-17 至 2023-07-31
关键词:
AwardBrain NeoplasmsDisciplineEnsureFacultyFosteringFutureGrantHumanIndividualLeadershipLengthMalignant neoplasm of brainMentorsMinorityMonitorProcessProgress ReportsPublicationsRequest for ApplicationsResearchResearch PersonnelScientistSourceStructureSystemTalentsTrainingWomananticancer researchbasecareercareer developmentfaculty mentorflexibilityinterestmeetingsneuro-oncologyprogramsrecruitsymposiumtranslational approach
中文摘要
职业提升计划:总结
西北脑肿瘤孢子(NBTS)职业提升计划(CEP)负责
招募和培训致力于神经肿瘤学研究的新的和早期研究者,以确保
将有源源不断的有才能的调查人员致力于这一领域。事实上,
导师来自不同的部门和学科提供了多样性和科学的来源
为获奖者提供专业知识。CEP接收者是在广泛征求申请后选出的,
申请和仔细审查申请人的证书和潜力,以发展一个独立的职业生涯,
脑肿瘤研究CEP领导层,詹姆斯博士和莱斯尼亚克博士,将特别努力强调
妇女和少数民族在SPORE CEP的获奖者和
导师
CEP在提供奖励和奖励期限方面具有灵活性。然而,有一个一致的
* 有一个高度结构化的程序,用于征求和选择CEP调查员,并有一个详细的跟踪系统
监测他们的进展。该方案的具体目标是:
1.维持职业提升计划的行政架构。
2.通过一个高度结构化的过程来招募和选择职业发展调查员。
3.通过与以下人员的单独会议,指导和持续评估职业发展调查员
导师,在SPORE研究者工作进展会议上一年两次的报告和书面进展
报道
4.培养新的教师走上神经肿瘤学的职业生涯,以确保未来的人才来源
致力于脑癌研究的研究人员。
!
英文摘要
CAREER ENHANCEMENT PROGRAM: SUMMARY
The Northwestern Brain Tumor SPORE (NBTS) Career Enhancement Program (CEP) is responsible for
recruitment and training of new and early stage investigators committed to neuro-oncology research to ensure
that there will be a continuous source of talented investigators committed to this field. The fact that the faculty
mentors come from a variety of departments and disciplines provides a source of diversity and scientific
expertise to program awardees. CEP recipients are selected after wide solicitation of the request for
applications and careful review of applicants' credentials and potential to develop an independent career in
brain tumor research. The CEP leadership, Drs. James and Lesniak, will make special efforts to emphasize
the recruitment of women and minorities to the SPORE CEP, both at the levels of award recipients and
mentors.
The CEP has flexibility in terms of offering awards and the length of the award. However, there is a consistent
and highly-structured process for solicitation and selection of CEP investigators and a detailed tracking system
for monitoring their progress. The specific aims of the CEP are:
1. To maintain an administrative structure for the Career Enhancement Program.
2. To solicit and select career enhancement investigators through a highly structured process.
3. To mentor and continuously evaluate career enhancement investigators through individual meetings with
mentors, bi-annual presentations at SPORE investigator work in progress meetings and written progress
reports.
4. To cultivate new faculty to embark on careers in neuro-oncology to ensure a future source of talented
investigators committed to brain cancer research.
!
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SLFN5: A Novel Therapeutic Target for Glioblastoma
-
批准号:10240565
-
项目类别:
-
资助金额:$34.56万
-
财政年份:2019
-
负责人:Charles David James
-
依托单位:
SLFN5: A Novel Therapeutic Target for Glioblastoma
-
批准号:10468276
-
项目类别:
-
资助金额:$34.56万
-
财政年份:2019
-
负责人:Charles David James
-
依托单位:
Career Enhancement Program
-
批准号:10224129
-
项目类别:
-
资助金额:$9.71万
-
财政年份:2018
-
负责人:Charles David James
-
依托单位:
BRAF Mutation in Malignant Astrocytoma Origin, Evolution, and Response to Therapy
-
批准号:9134221
-
项目类别:
-
资助金额:$35.65万
-
财政年份:2014
-
负责人:Charles David James
-
依托单位:
BRAF Mutation in Malignant Astrocytoma Origin, Evolution, and Response to Therapy
-
批准号:8901528
-
项目类别:
-
资助金额:$35.2万
-
财政年份:2014
-
负责人:Charles David James
-
依托单位:
PRE-CLINICAL ANIMAL CORE
-
批准号:8514330
-
项目类别:
-
资助金额:$16.49万
-
财政年份:2013
-
负责人:Charles David James
-
依托单位:
NOVEL APPROACAHES FOR IMPROVING PEDIATRIC BRAFV600E GLIOMA PATIENT OUTCOMES
-
批准号:8514312
-
项目类别:
-
资助金额:$27.15万
-
财政年份:2013
-
负责人:Charles David James
-
依托单位:
BRAF Mutation in Malignant Astrocytoma Origin, Evolution, and Response to Therapy
-
批准号:8402661
-
项目类别:
-
资助金额:$35.22万
-
财政年份:2012
-
负责人:Charles David James
-
依托单位:
Cdk4/6 Inhibitor Therapy for Glioblastoma Multiforme
-
批准号:8658297
-
项目类别:
-
资助金额:$31.2万
-
财政年份:2012
-
负责人:Charles David James
-
依托单位:
Cdk4/6 Inhibitor Therapy for Glioblastoma Multiforme
-
批准号:8840899
-
项目类别:
-
资助金额:$32.16万
-
财政年份:2012
-
负责人:Charles David James
-
依托单位:
Cdk4/6 Inhibitor Therapy for Glioblastoma Multiforme
-
批准号:8314300
-
项目类别:
-
资助金额:$33.49万
-
财政年份:2012
-
负责人:Charles David James
-
依托单位:
BRAF Mutation in Malignant Astrocytoma Origin, Evolution, and Response to Therapy
-
批准号:8529270
-
项目类别:
-
资助金额:$34.11万
-
财政年份:2012
-
负责人:Charles David James
-
依托单位:
Cdk4/6 Inhibitor Therapy for Glioblastoma Multiforme
-
批准号:8463483
-
项目类别:
-
资助金额:$30.22万
-
财政年份:2012
-
负责人:Charles David James
-
依托单位:
EGRF Targeting of Therapeutic Liposomes for Treating Gliobastoma
-
批准号:7843605
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2009
-
负责人:Charles David James
-
依托单位:
Xenograft Model for Studying Amplified EGFR in GBM
-
批准号:6825627
-
项目类别:
-
资助金额:$30.12万
-
财政年份:2004
-
负责人:Charles David James
-
依托单位:
Xenograft Model for Studying Amplified EGFR in GBM
-
批准号:7228952
-
项目类别:
-
资助金额:$30.37万
-
财政年份:2004
-
负责人:Charles David James
-
依托单位:
Core--Xenograft Facility
-
批准号:6844503
-
项目类别:
-
资助金额:$16.36万
-
财政年份:2004
-
负责人:Charles David James
-
依托单位:
Xenograft Model for Studying Amplified EGFR in GBM
-
批准号:7405313
-
项目类别:
-
资助金额:$30.46万
-
财政年份:2004
-
负责人:Charles David James
-
依托单位:
Xenograft Model for Studying Amplified EGFR in GBM
-
批准号:6928574
-
项目类别:
-
资助金额:$28.93万
-
财政年份:2004
-
负责人:Charles David James
-
依托单位:
Xenograft Model for Studying Amplified EGFR in GBM
-
批准号:7276913
-
项目类别:
-
资助金额:$28.25万
-
财政年份:2004
-
负责人:Charles David James
-
依托单位:
海外基金